期刊文献+

急性期球囊及支架辅助栓塞破裂型颅内动脉瘤 被引量:5

The therapeutic effect of balloon-assisted coiling and stent-assisted coiling of ruptured intracranial aneurysms in the acute phase
原文传递
导出
摘要 目的探讨在急性期球囊辅助与支架辅助栓塞颅内破裂动脉瘤的治疗效果。方法收集首都医科大学附属北京朝阳医院2014年1月至2016年12月,在急性期采用球囊或支架辅助技术栓塞的91枚破裂颅内动脉瘤患者资料。其中球囊辅助栓塞37例,支架辅助栓塞54例。采用回顾性分析的设计方法,用卡方分析比较两组患者的一般情况、动脉瘤的位置分布、形态、围手术期并发症及预后。结果球囊辅助栓塞组的动脉瘤颈宽度明显小于支架辅助栓塞组[(3.31±1.63)mm vs(4.35±2.10)mm,P=0.01)],球囊辅助栓塞瘤体/瘤颈的值低于支架辅助栓塞组[(1.64±0.46)vs.(1.35±0.66),P=0.025)];球囊辅助栓塞组复发率高于支架辅助栓塞组(18.9%vs.0.9%,P=0.005)。球囊辅助栓塞组与支架辅助栓塞组的围手术期并发症比较差异无统计学意义。支架辅助组术后有两例患者手术相关性颅内出血而死亡;患者术后6个月随访的改良Modified Rankin Score(mRS)评分(0~2分),球囊辅助栓塞组高于支架辅助栓塞组(94.6% vs.88.9%,P=0.028)。结论球囊辅助栓塞组与支架辅助栓塞组的围手术期并发症比较差异无统计学意义。球囊辅助栓塞的患者预后相对较好,但更易复发;而支架辅助栓塞适用于瘤颈更宽的动脉瘤。对于相对宽颈的急性期破裂动脉瘤,首先采用球囊辅助栓塞,再择期支架辅助栓塞,也是治疗选择之一。 Objective To investigate the perioperative complications and therapeutic effects of balloon-assisted coiling (BAC)and stent-assisted coiling (SAC)in patients with ruptured intracranial aneurysms in the acute phase.Methods Totally 91patients with 91intracranial ruptured aneurysms were treated with BAC or SAC in our hospital between January 2014and December 2016.Among them,37patients were treated with BAC and 54patients with SAC respectively.Of the two groups,the position distribution and shape of aneurysms,and the complications after procedures and the therapeutic effects were summarized and evaluated retrospectively using chi-square test.Results The width of the aneurysm neck was narrower in the BAC-treated group compared to the SAC-treated group (3.31±1.63 mm vs.4.35±2.10mm,P=0.01).The aneurysm body/neck ratio (B/N)was lower in the BAC-treated group than in the SAC-treated group (1.64±0.46vs.1.35±0.66,P=0.025).The recurrence rate was higher in the BAC-treated group than that in the SAC-treated group(18.9%vs.0.9%,P=0.005).There was no statistical difference in perioperative complication in both the BAC-treated group and SAC-treated group. However,2 patients died due to the relative postoperative intracranial bleeding in the SAC-treated group. Better outcomes (Modified Rankin Score,mRS,0-2)were achieved in the BAC-treated group compared to the SAC-treated group (94.6% vs.88.9%,P=0.028)at the follow-up visit.Conclusions These findings suggested that there is no difference between the BAC-treated group and the SAC-treated group in the risk of complication.BAC can achieve a better prognosis,but it is more prone to relapse.The SAC method was more appropriate for wider neck aneurysms.It was also an option to coiling the aneurysm in BAC in acute phase firstly,followed by additional treatment in SAC during the follow-up period.
作者 刘赫 辛百龙 李彤 钟红亮 贾建文 孙永全 郭树彬 Liu He;Xin Bailong;Li Tong;Zhong Hongliang;Jia Jianwen;Sun Yongquan;Guo Shubin(Department of lnterventional Neurological Radiology,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China;Department of Neurosurgery,Huhhout NO.1Hospital,Huhhott 014010,China;Department of Emergency,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China)
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2018年第12期1333-1336,共4页 Chinese Journal of Emergency Medicine
关键词 急性期 破裂性动脉瘤 球囊辅助栓塞 支架辅助栓塞 Acute phase Ruptured aneurysm Balloon-assisted coiling Stent-assisted coiling
  • 相关文献

参考文献4

二级参考文献12

  • 1Zhnu SS, Tian F, Chen YD, et al. Combination therapy reduces the incidence of no-re-flow after primary percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction [J]. J Geriatr Cardiol , 2015, 12: 135-142.
  • 2Akpek M, Sahin O, Sarli B, et al. Acute Effects of Intracoronary tirofiban on no-reflow phenomena in patients with ST segment elevated myocardial infarction undergoing primary percutaneous coronary intervention [J]. Angiology, 2015, 66: 560-567.
  • 3Durate A, Camici PG. Novel insights into an "old" phenomenon: the no reflow [J] . Int J Cardiol, 2015, 187: 273-280.
  • 4Kaul S. The " no reflow " phenomenon and following actue myocardial infarction: Mechanisms and treatment option [J].J Cardiol, 2014, 64 (1):77-85.
  • 5Jaffe R, Dick A , Strauss BH. Prcvenition and treatment of microvascular obstructi-on-related myocardial injury and coronary no-reflow following percutaneous coronary intervention : a systematic approach [J].JACC Cardiovasclnterv, 2010, 3 (7) : 95-704.
  • 6Vant hof AW, Valgimiglim. Defining the role of platelet glycoprotein recertor Inhibitors in STEMI: focus on tirfiban [ J]. Drugs, 2009, 69 ( 1 ) : 85-100.
  • 7Vant hof AW, TEN BERG J, HEESTERMANST, et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty ( On- TIMI2): a multieentre , double-blind , randomized contyolled trial [J]. Lancet, 2008, 16 (3): 537-546.
  • 8Warnhoitz A, Ostad MA, Heitzer T , et al. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease [J]. Am J Cardiol, 2005, 95 (1): 20-23.
  • 9L.Pierot,L.Spelle,X.Leclerc,C.Cognard,A.Bonafeé,J.Moret,关祥祯.未破裂颅内动脉瘤的血管腔内治疗:成形术与标准弹簧圈治疗安全性的比较[J].国际医学放射学杂志,2009,32(4):395-396. 被引量:21
  • 10韩轶鹏,王大明,姜宏志,沙成,刘加春,王利军,陆军,祁鹏.老年人自发性蛛网膜下腔出血诊治临床分析[J].中华老年医学杂志,2010,29(2):123-126. 被引量:3

共引文献24

同被引文献65

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部